Ondansetron
- Product NDC
- 43063-592
- 11-digit product format
- 430630592
- Labeler code
- 43063
- Product ID
- 43063-592_a8d9e148-9012-6ed1-e053-2995a90ac2a6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ondansetron
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Application
- ANDA078050
- Marketing category
- ANDA
- Marketing start
- 2007-08-13
- Marketing end
- 0000-00-00
- Substance
- ONDANSETRON
- Active strength
- 8 mg/1
- Pharmacologic classes
- Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 43063-592-04 | 43063059204 | 4 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, PLASTIC (43063-592-04) | 2017-12-26 | 0000-00-00 | No | No | Current |
| 43063-592-10 | 43063059210 | 10 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, PLASTIC (43063-592-10) | 2014-12-04 | 0000-00-00 | No | No | Current |